352 related articles for article (PubMed ID: 32829671)
1. Adeno-Associated Virus Vector Mobilization, Risk Versus Reality.
Song L; Samulski RJ; Hirsch ML
Hum Gene Ther; 2020 Oct; 31(19-20):1054-1067. PubMed ID: 32829671
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
3. Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems.
Lin YC; Lu M; Cai W; Hu WS
Appl Microbiol Biotechnol; 2024 Jun; 108(1):385. PubMed ID: 38896252
[TBL] [Abstract][Full Text] [Related]
4. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
Whiteway A; Deru W; Prentice HG; Anderson R
J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
[TBL] [Abstract][Full Text] [Related]
5. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.
Xiao X; Li J; Samulski RJ
J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080
[TBL] [Abstract][Full Text] [Related]
6. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis.
Philpott NJ; Giraud-Wali C; Dupuis C; Gomos J; Hamilton H; Berns KI; Falck-Pedersen E
J Virol; 2002 Jun; 76(11):5411-21. PubMed ID: 11991970
[TBL] [Abstract][Full Text] [Related]
7. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
8. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
9. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
10. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
[TBL] [Abstract][Full Text] [Related]
11. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
Shiau AL; Liu PS; Wu CL
J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
[TBL] [Abstract][Full Text] [Related]
12. Role for highly regulated rep gene expression in adeno-associated virus vector production.
Li J; Samulski RJ; Xiao X
J Virol; 1997 Jul; 71(7):5236-43. PubMed ID: 9188591
[TBL] [Abstract][Full Text] [Related]
13. Detection of adeno-associated virus type 2 in sorted human bone marrow progenitor cells.
Anderson RJ; Galatowicz G; Macdonald ID; Lowdell MW; Corbett TJ; Prentice HG
Exp Hematol; 1997 Mar; 25(3):256-62. PubMed ID: 9091303
[TBL] [Abstract][Full Text] [Related]
14. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
16. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production.
Okada T; Mizukami H; Urabe M; Nomoto T; Matsushita T; Hanazono Y; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2001 Oct; 288(1):62-8. PubMed ID: 11594752
[TBL] [Abstract][Full Text] [Related]
18. Adeno-Associated Virus Monoinfection Induces a DNA Damage Response and DNA Repair That Contributes to Viral DNA Replication.
Ning K; Kuz CA; Cheng F; Feng Z; Yan Z; Qiu J
mBio; 2023 Feb; 14(1):e0352822. PubMed ID: 36719192
[TBL] [Abstract][Full Text] [Related]
19. Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system.
Feudner E; de Alwis M; Thrasher AJ; Ali RR; Fauser S
J Virol Methods; 2001 Aug; 96(2):97-105. PubMed ID: 11445141
[TBL] [Abstract][Full Text] [Related]
20. Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes.
Mamounas M; Leavitt M; Yu M; Wong-Staal F
Gene Ther; 1995 Aug; 2(6):429-32. PubMed ID: 7584119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
